Breo Ellipta: Asthma HCP Banner Ad




Brand: Breo Ellipta (fluticasone furoate and vilanterol), Inhalation Powder
Parent Company: GSK
Drug Type: Boxed Warning
Drug Category: Immunology
Campaign: Post-Launch
Targeting: HCPs
Patient Website: http://www.mybreo.com/
HCP Website: https://www.gsksource.com/pharma/content/gsk/source/us/en/brands/breo.html

This 300×250 Breo Ellipta HCP ad is fairly conservative, likely due to the fact that it is a boxed warning drug (“black box”). It tries to conveys its main message right in the banner, although placing 31 words (frame 5 in the screenshot, not counting the logo and scrolling ISI), or 22 (last frame) on a banner ad is never a good idea.